000 01130 a2200289 4500
005 20250514195913.0
264 0 _c20041201
008 200412s 0 0 eng d
022 _a1570-1611
024 7 _a10.2174/1570161033386790
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChavakis, Triantafyllos
245 0 0 _aPotential pharmacological applications of the antithrombotic molecule high molecular weight kininogen.
_h[electronic resource]
260 _bCurrent vascular pharmacology
_cMar 2003
300 _a59-64 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aFibrinolytic Agents
_xchemistry
650 0 4 _aHumans
650 0 4 _aKininogen, High-Molecular-Weight
_xchemistry
650 0 4 _aPlatelet Aggregation
_xdrug effects
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThromboembolism
_xmetabolism
700 1 _aPreissner, Klaus T
773 0 _tCurrent vascular pharmacology
_gvol. 1
_gno. 1
_gp. 59-64
856 4 0 _uhttps://doi.org/10.2174/1570161033386790
_zAvailable from publisher's website
999 _c15019014
_d15019014